Page last updated: 2024-09-04

ampelopsin and Renal Insufficiency, Chronic

ampelopsin has been researched along with Renal Insufficiency, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, M; Feng, L; Li, Z; Ou, C; Que, D; Wei, J; Yan, J; Yang, P; Zhang, X; Zhong, X	1

Other Studies

1 other study(ies) available for ampelopsin and Renal Insufficiency, Chronic

Article	Year
Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Clinical science (London, England : 1979), 2021, 11-12, Volume: 135, Issue:21 Topics: Animals; Aorta; Aortic Diseases; Cells, Cultured; Disease Models, Animal; Flavonols; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Vascular Calcification	2021

Article

Year

Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling.

Clinical science (London, England : 1979), 2021, 11-12, Volume: 135, Issue:21

Topics: Animals; Aorta; Aortic Diseases; Cells, Cultured; Disease Models, Animal; Flavonols; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Vascular Calcification

2021